Document is current

Article History

Received: 6 December 2024

Revised: 30 January 2025

Accepted: 2 February 2025

First Online: 15 February 2025

Declarations

:

: Dr Vassilaki reported receiving research funding from F. Hoffmann-La Roche Ltd and Biogen in the past and consults for F. Hoffmann-La Roche Ltd., receiving research funding from NIH and has equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic and Amgen. Dr Kremers reported receiving research support from the National Institutes of Health. Dr Knopman serves on a Data Safety Monitoring Board for the DIAN study, is an investigator in clinical trials sponsored by Lilly Pharmaceuticals, Biogen and the Alzheimers Treatment and Research Institute at USC, and reported receiving research support from the National Institutes of Health. Dr Petersen is a consultant for Roche, Inc., Biogen, Inc., Merck, Inc., Eisai, Inc., Genentech, Inc. and Nestle, Inc., reported receiving publishing royalties from Mild Cognitive Impairment (Oxford University Press, 2003), UpToDate and reported receiving research support from the National Institutes of Health. Dr Berry reported receiving royalties, consulting fees and/or stock options from Elsevier, Wolters Kluwer, Journal of Bone and Joint Arthroplasty, Depuy, Bodycad, has leadership roles in Orthopaedic Research and Education Foundation, International Hip Society, Knee Society, International Society of Arthroplasty Registries, Current Concepts in Joint Replacement, Journal of Bone and Joint Surgery, reported receiving research support from the National Institutes of Health. Dr Lewallen reported receiving royalties, consulting fees and/or stock options from Zimmer Biomet, Ketai Medical Devices, Accuitive, reported receiving research support from the National Institutes of Health. Dr Maradit Kremers reported receiving research support from the National Institutes of Health.